Torrent Pharmaceuticals (Torrent) has completed acquisition of branded formulation business of Unichem Laboratories (Unichem) for India and Nepal, including its Sikkim manufacturing facility, on a going concern basis by way of slump sale, on December 14, 2017. This transaction was in pursuance of the definitive binding agreement entered into between Torrent and Unichem on November 3, 2017.
From today, Torrent begins the integration of the Unichem business following the successful closure of its acquisition. The integration will aim to fuel and support strong growth of the acquired Unichem brands, consolidating speciality reach with a relentless focus on enhancing productivity. The acquisition will accelerate Torrent’s presence in the chronic space especially in the high growth segments of Indian Pharma market like Cardiology, Diabetology and Gastroenterology. Moreover, Unichem brings in an important new platform in Torrent’s sustainable growth strategy by expanding the company’s presence in the OTC segment.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1215.35 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 947.05 |
View more.. |